Skip to content
Presidential·Exec Order·2 months ago

Trump Orders DOJ to Fast-Track Marijuana Rescheduling to Schedule III

Impact Analysis

Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)

Key Points

  • The President is directing the Department of Justice to quickly finish moving marijuana from the most restrictive drug category to a lower one called Schedule III. This change recognizes that marijuana has accepted medical uses, such as treating chronic pain and nausea, and makes it much easier for scientists to study its benefits and risks.
  • The order aims to help the more than 6 million Americans who already use medical marijuana across 40 states. Currently, strict federal rules make it hard for doctors to give clear advice on how to use it safely. New research will help healthcare providers understand the right dosages and how marijuana might react with other medications.
  • Government agencies like the FDA and the National Institutes of Health will create new ways to study how people use marijuana and CBD in their daily lives. This research will focus on how these products affect specific groups, including seniors who use them for pain relief and young adults who may face different long-term health effects.
  • The White House will work with Congress to update rules for hemp-derived CBD products. The goal is to create a better system for labeling these products and setting limits on how much THC they can contain. This ensures that people buying CBD for health reasons are getting safe, accurately labeled products.
HealthcareCriminal JusticeAgriculture

What Happens Next

Projected impacts based on AI analysis

Attorney General begins expediting the marijuana rescheduling rulemaking process, including the pending administrative law hearing

The legal process to move marijuana from Schedule I to Schedule III gets fast-tracked, but the hearing and final rule could still take months to over a year to complete

Federal agencies begin developing research frameworks for medical marijuana and CBD products

HHS, FDA, CMS, and NIH start building new ways to study real-world marijuana and CBD use, which will eventually lead to better medical guidance for patients and doctors

Related News

5 articles
Drugs.com·2 months ago

Trump Signs Order to Expand Medical Cannabis Research

President Trump signed an executive order to expedite the rescheduling of marijuana to Schedule III, aiming to facilitate research into chronic pain and nausea. The order directs the DOJ and HHS to remove barriers for scientists studying the benefits and risks for 6 million medical users.

C=
Fox Business·3 months ago

Reclassifying marijuana as a Schedule III drug opens door to medical research into its 'positive attributes'

Industry leaders and medical experts discuss how the White House's move to reclassify marijuana will allow for more rigorous clinical trials. The shift recognizes the drug's medical potential and seeks to provide clearer guidance for healthcare providers and patients.

CR+
NewsNation·3 months ago

Rescheduling marijuana would make 'medical research' easier: Journalist

Reporting highlights that moving marijuana to Schedule III will reduce the 'red tape' that has historically blocked scientists. While supporters cheer the expansion of research for veterans and seniors, critics express concern over the drug's potential as a gateway substance.

C~

Source Information

Signed By

Document Type

Executive Order

Official Title

Increasing Medical Marijuana and Cannabidiol Research

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.